Loren Data's SAM Daily™

SAMDAILY.US - ISSUE OF JUNE 19, 2021 SAM #7140
SOLICITATION NOTICE

Q -- Collection and analysis of specimens for COVID-19 vaccination and outcomes for NIH protocol

Notice Date

6/17/2021 8:57:45 AM
 

Notice Type

Presolicitation
 

NAICS

541380 — Testing Laboratories
 

Contracting Office

NATIONAL INSTITUTES OF HEALTH NIAID BETHESDA MD 20892 USA
 

ZIP Code

20892
 

Solicitation Number

NOI-NIAID-2082181
 

Response Due

6/25/2021 2:00:00 PM
 

Archive Date

07/10/2021
 

Point of Contact

Dana Monroe, Phone: 4063759814
 

E-Mail Address

dana.monroe@nih.gov
(dana.monroe@nih.gov)
 

Description

PRE-SOLICITATION NOTICE NOI-NIAID-2082182 NAICS � 541380 This is a Notice of Intent, not a request for proposal.� The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) intends to negotiate on an other than full and open competition basis with Quest Diagnostics Clinical Laboratories, Inc to procure services for the collection and analysis of specimens for the immune response to COVID-19 vaccination and outcomes in individuals with and without immune deficiencies and dysregulations to be used by NIH protocol 20I0083 to conduct COVID-19 serosurvey in the U.S. Quest Diagnostics Clinical Laboratories, Inc services will be used to continue existing research for NIH protocol 20I0083 to conduct a COVID-19 serosurvey in the US. This cohort study will assess the pre- and post-vaccination immune responses in individuals with select immune disorders compared to healthy volunteers who receive a coronavirus disease 2019 (COVID-19) vaccine. Subjects will undergo venous blood draws up to 6 times (pre-vaccination, 1-month post dose 1, 1-month post dose 2, 6, 12, and 24 months). Because the majority of participants will be remote and not traveling to NIH for sample collection, options were needed to have blood drawn where a participant lives. Quest Diagnostics Clinic Laboratories are available through nationwide networks.� This company has the capacity to establish national contracts for research purposes. In order to keep results comparable within the nationwide pool required for this protocol, and to adhere to the continuation of existing studies already in place, NIH requires that the services retain consistency and replicability and consolidated billing process. The statutory authority for this sole source requirement is 41 U.S.C. 1901 (a) (1) as implemented by FAR 13.106-1 only one responsible source and no other supply of service will satisfy agency requirements. THIS IS NOT A REQUEST FOR PROPOSAL.� All responsible sources that could provide comparable services may submit a capability statement that will be considered by email (subject line to reference NOI-NIAID-2082182) to Dana Monroe at dana.monroe@nih.gov, by 5:00pm pacific daylight savings time Friday, June 25, 2021. �All responses received by the closing date of this synopsis will be considered by the Government.� A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government.
 

Web Link

SAM.gov Permalink
(https://beta.sam.gov/opp/850bafc176004f6b9d4dfa71375332c0/view)
 

Place of Performance

Address: Rockville, MD 20852, USA

Zip Code: 20852

Country: USA
 

Record

SN06034922-F 20210619/210618201531 (samdaily.us)
 

Source

SAM.gov Link to This Notice
(may not be valid after Archive Date)

---

| FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |